A cyber attack hit LiteLLM, an open-source library used in many AI systems, carrying malicious code that stole credentials ...
After hacking Trivy, TeamPCP moved to compromise repositories across NPM, Docker Hub, VS Code, and PyPI, stealing over 300GB ...
The compromised packages, linked to the Trivy breach, executed a three‑stage payload targeting AWS, GCP, Azure, Kubernetes ...
Veeva Systems, which offers life sciences companies cloud-based commercial management software and business consulting services, is venturing into the consumer-facing side of things with the ...
The deal signals Veeva’s push to expand artificial intelligence tools that help pharmaceutical brands interact with patients and healthcare professionals. The transaction adds an AI-powered engagement ...
Veeva Systems reported fourth-quarter revenue of $836 million, up 16% year-over-year. The revenue total beat a Street consensus estimate of $810.6 million, according to data from Benzinga Pro. The ...
Veeva's laser focus on the life sciences industry has made it a leader in this corner of the cloud market. The company could grow its revenue -- and share price -- at a good clip in the next four ...
The past six months have been rough for Veeva Systems (NYSE: VEEV). The stock has declined 35% over this period as the market fears that mounting competition will lead to disappointing financial ...
As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...
The latest announcement is out from Veeva Systems ( (VEEV)). On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the ...
Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now. On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to ...
Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results